LignaMed Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $6.62M

  • Investors
  • 4

LignaMed General Information

Description

Developer of molecule therapy intended to offer breakthrough treatments for severe asthma, organ transplant viability, and fibrosis. The company develops therapeutics from flaxseed derivatives obtained through proprietary synthesis processes and also offers an oral treatment for asthma, to salvage donor lung organs that are currently not suitable for a lung transplant, enabling patients to improve donor lung storage conditions and extend the donor lung preservation period, as an oral treatment for pulmonary fibrosis control and in some cases reverse the progression of the disease.

Contact Information

Website
www.lignamed.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3675 Market Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3675 Market Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LignaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 01-Jan-2020 $6.62M Completed Startup
7. Grant 01-Jan-2019 Completed Startup
6. Grant 01-Sep-2018 Completed Startup
5. Grant 01-Jan-2018 Completed Startup
4. Grant 18-Jul-2017 Completed Startup
3. Grant 01-Jan-2017 Completed Startup
2. Accelerator/Incubator 10-Mar-2015 Completed Startup
1. University Spin-Out 01-Jan-2013 Completed Startup
To view LignaMed’s complete valuation and funding history, request access »

LignaMed Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

LignaMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200181187-A1 Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside Inactive 12-Jun-2017
JP-2020523394-A Method for producing (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside Pending 12-Jun-2017
EP-3638220-A1 Process for the preparation of (s,s Pending 12-Jun-2017
AU-2018283958-A1 Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside Active 12-Jun-2017
AU-2018283958-B2 Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside Inactive 12-Jun-2017 C07H15/18
To view LignaMed’s complete patent history, request access »

LignaMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LignaMed Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Heart, Lung, and Blood Institute Government
National Aeronautics and Space Administration Government
National Institute for Allergy and Infectious Disease Government
Penn Center for Innovation Accelerator/Incubator
To view LignaMed’s complete investors history, request access »

Ready to get started?

Request a free trial

LignaMed FAQs

  • When was LignaMed founded?

    LignaMed was founded in 2013.

  • Where is LignaMed headquartered?

    LignaMed is headquartered in Philadelphia, PA.

  • What is the size of LignaMed?

    LignaMed has 3 total employees.

  • What industry is LignaMed in?

    LignaMed’s primary industry is Biotechnology.

  • Is LignaMed a private or public company?

    LignaMed is a Private company.

  • What is LignaMed’s current revenue?

    The current revenue for LignaMed is .

  • Who are LignaMed’s investors?

    National Heart, Lung, and Blood Institute, National Aeronautics and Space Administration, National Institute for Allergy and Infectious Disease, and Penn Center for Innovation have invested in LignaMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »